Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects (Q42498869)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects |
scientific article |
Statements
1 reference
Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects (English)
1 reference
Jerrold M Olefsky
1 reference
Gautam K Bandyopadhyay
1 reference
Joseph G Yu
1 reference
Jachelle Ofrecio
1 reference
1 August 2006
1 reference
Identifiers
1 reference